Uniphar

FY2025 trading statement reflects record organic growth

  • Sectors : Pharma and healthcare
  • Companies : Uniphar

Ratings and price correct at time of issue.

  • Uniphar

    Closing Price: 359c

  • RATING 27/08/19

  • PREVIOUS RATING N/A

DAVY VIEW

Uniphar has reported an extremely strong trading statement for FY2025. Organic gross profit growth of 9% is a record level and has translated into 21% EPS growth, which will drive upgrades to forecasts. Net debt is below forecast and all targets have been reiterated. Our €5.00 price target is now very conservative.

Download full report with analyst certification and important disclosures

Jan 27 2026, 07:10 GMT

Download